Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · ROSSARI

ROSSARI

CommoditiesChemicals & Petrochemicals₹2389 cr market cap
₹428.00 ▼ -1.1% today As of 19 Nov 2026
52-week low ₹378.6052-week high ₹634.65

-31.8% from the 52-week high · +14.3% above the low

Rossari Biotech Ltd. operates as a specialty chemicals manufacturing company. The company is headquartered in Mumbai, Maharashtra and currently employs 500 full-time employees. The company went IPO on 2020-07-23. The firm is engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. The company operates through three segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). HPPC produces acrylic polymers, manufacturing a sustainable range of products for various applications in the cleaning industry. TSC is focused on providing customers with eco-friendly, sustainable chemical solutions. The company provides solutions for pre-treatment, dyeing and printing, finishing, and specialty chemicals for the entire value chain of the textile industry. AHN provides wellness solutions for pet animals and poultry, focusing on their health and performance.

The short version. ROSSARI reported revenue of ₹698 crore for Sep 2026, up 19.1% from a year earlier. Net profit was ₹39 crore (up 5.4% year on year). Return on equity was 11.2% in Mar 2026. Promoter holding was 68.14% in Sep 2026, down 0.05 points over 8 quarters.

1 · The price

How has the stock traded?

ROSSARI trades 31.8% below its 52-week high and 14.3% above its 52-week low.

Change over period: —

1M-1.1%
3M-12.8%
6M-14.7%
1Y-31.0%

2 · The business

Is it growing?

Sales, year on year+19.1%

Sep 2026 revenue of ₹698 cr.

Profit, year on year+5.4%

Sep 2026 net profit of ₹39 cr.

Net margin5.6%

0.7 pts lower than a year earlier.

3-year growth11.6% profit

Revenue compounded at 13.3% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue698697685582586544580513
Net profit3935463337343432
Net margin %5.65.06.75.66.36.25.96.2
EPS (₹)7.026.348.35.926.666.076.225.73

Annual

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue23962080183116561483709
Net profit1491361311079880
Net margin %6.26.67.16.56.611.3
EPS (₹)26.9424.6323.6619.4517.7415.45

3 · The quality

How well does it turn capital into profit?

Return on equity was 11.2% in Mar 2026; debt to equity is 0.31.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %11.211.512.511.7
Return on capital %15.314.917.216.2
EBITDA margin %12.812.914.013.8
Net margin %6.26.57.16.5

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR13.3%27.5%
Profit CAGR11.6%13.2%
Debt to equity0.31
Interest cover8.0x
Current ratio1.57
P/E ratio15.7

4 · The owners

Who holds it, and are they adding?

Promoter holding68.14%

Down 0.05 pts over 8 quarters.

Foreign institutions1.84%

Down 1.9 pts over 8 quarters.

Domestic institutions14.19%

Down 3.28 pts over 8 quarters.

Mutual fund schemes9

+1 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter68.1968.1868.1768.1768.1668.1568.1468.14-0.05
FII3.743.983.482.692.332.182.021.84-1.9
DII17.4717.5917.8418.1818.2618.214.6414.19-3.28
Public10.610.2510.5110.9511.2611.4615.215.83+5.23

Mutual fund holdings · Oct 2026

9 schemes hold this stock

8 the month before.

  • UTI Small Cap Fund0.48% of NAV
  • UTI Multi Cap Fund0.39% of NAV
  • CANARA ROBECO SMALL CAP FUND0.31% of NAV
  • UTI - Flexi Cap Fund0.3% of NAV
  • UTI Large & Mid Cap Fund0.21% of NAV
  • UTI Aggressive Hybrid Fund0.18% of NAV
  • MOTILAL OSWAL SMALL CAP FUND0.17% of NAV
  • UTI Retirement Fund0.11% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for ROSSARI are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about ROSSARI

What is the ROSSARI share price?

ROSSARI (ROSSARI) last closed at ₹428.00, down 1.1% on the day. Its 52-week range is ₹378.60 to ₹634.65.

What is the market cap of ROSSARI?

ROSSARI has a market capitalisation of about ₹2,389 crore. Its price-to-earnings ratio is 15.7.

How are ROSSARI's latest results?

ROSSARI reported revenue of ₹698 crore for Sep 2026, up 19.1% from a year earlier. Net profit was ₹39 crore (up 5.4% year on year). Return on equity was 11.2% in Mar 2026. Promoter holding was 68.14% in Sep 2026, down 0.05 points over 8 quarters.

Who owns ROSSARI?

As of Sep 2026, shareholding was: Promoter 68.14%, FII 1.84%, DII 14.19%, Public 15.83%.

How many mutual funds hold ROSSARI?

9 mutual fund schemes held ROSSARI in October 2026. That compares with 8 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 10 Jul 2026 · Final Dividend - Rs. 0.5
  • 20 Jun 2025 · Final Dividend - Rs. 0.5
  • 16 Aug 2024 · Final Dividend - Rs. 0.5
  • 24 May 2023 · Final Dividend - Rs. 0.5
  • 07 Jul 2022 · Final Dividend - Rs. 0.5
  • 08 Sep 2021 · Final Dividend - Rs. 0.5

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.